Study: Single Troponin Test, ECG Enough to Identify Risk of Heart Attack

A single troponin level measurement test and an electrocardiogram may be sufficient to rule out the risk of a heart attack in patients complaining of chest pain, according to a study in the Journal of the American College of Cardiology.

Advertisement

Researchers studied patient data from more than 14,000 patients over two years who visited the hospital due to chest pains and tested their high-sensitivity cardiac troponin levels.

The majority of patients, 99.8 percent, who had hs-cTnT levels less than 5 ng/l and no signs of ischemia on an ECG did not experience a heart attack within 30 days of being evaluated. Additionally, the negative predictive value for 30-day mortality was 100 percent.

Researchers concluded patients with “undetectable” hs-cTnT levels and a normal electrocardiogram have minimal risk of heart attack or death within 30 days and can be safely discharged from the emergency department.

More Articles on Clinical Quality:

15 Highest, Lowest Scoring Hospitals for Patient Safety
Flu Vaccine Reduces PICU Visits by 74%
Setting Your Facility Up for Success, One Huddle at a Time

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.